Xcout Intel
IOPtima
IOPtima Ltd. is a medical device developer located in Tel Aviv, Israel, operating as a Chengdu Kanghong Pharmaceutical company. The firm specializes in creating minimally-invasive surgical ophthalmic devices and advanced surgical solutions for eye care.
Subscribe to see IOPtima’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IOPtima at a glance
IOPtima is a healthcare company headquartered in Israel. Its most recent funding round raised $7.2M in November 2015. Xcout tracks 2 named people at IOPtima, including Eran Kaplan (Chief Executive Officer).
IOPtima leadership
- Eran KaplanChief Executive Officer
- Prof. Ehud AssiaInventor
IOPtima funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $7.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
IOPtima competitors
A few of IOPtima's closest competitors — see the full list of competitors and alternatives →
NanoDrops is a medical device company headquartered in Or Yehuda, Israel, founded in 2018 to develop a minimally invasive visual optical correction solution using superficial laser imprint technology and eye drops to enhance near vision in adults with presbyopia.
Smartlens, Inc. is a medical device company developing smart contact lenses for continuous 24-hour intraocular pressure monitoring, AI-powered eye imaging, and micro-dose drug delivery. Headquartered in California, the firm aims to transform glaucoma and anterior segment eye disease management.
ConTIPI Medical, located at the Caesarea Industrial Park in Israel, develops and provides non-surgical medical devices and solutions.
Beta-O2 is an Israeli medical-device company developing implantable bioartificial pancreas technology for people with type 1 diabetes. Its systems encapsulate insulin-producing pancreatic islets and provide supplemental oxygen to support islet survival and insulin production without systemic immunosuppression.
CorAssist Cardiovascular Ltd. was a clinical-stage medical device company based in Haifa, Israel, focused on developing therapeutic products for treating heart failure with preserved ejection fraction and diastolic heart failure. The company ceased operations in December 2022.
APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Get IOPtima's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on IOPtima in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access